2 completed, 1 recruiting, 1 unknown. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Oppositional Defiant Disorder: new trials by email Literature Review of Oppositional Defiant Disorder trials Research Report on Oppositional Defiant Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pathways 2 Success L2B, L2B + App, skills for success - Conduct Disorder, Oppositional Defiant Disorder | Phase 1 / Phase 2 | Recruiting | University of Minnesota | 120 | 2025-03-12 | 2026-04-13 |
| Task-Based Grounding Program Task-Based Grounding, Connected Care (Enhanced Treatment as usual) - Aggressive, Defiant Disorder, Oppositional | Phase 1 | Completed | Dartmouth-Hitchcock Medical Center | 28 | 2020-12-03 | 2021-11-08 |
| Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders Brexpiprazole - ADHD, Autism | Phase 1 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 24 | 2017-10-10 | 2018-06-12 |
| Treatment of Conduct Problems and Depression Integrated Treatment - Depression, Oppositional Defiant Disorder | Phase 1 | Unknown | Rhode Island Hospital | 30 | 2010-08-01 | 2013-03-21 |
Conduct Disorder (3) · Attention Deficit Disorder with Hyperactivity (2) · Aggression (1) · Autistic Disorder (1) · Central Nervous System Diseases (1) · Depression (1)
Attention Deficit and Disruptive Behavior Disorders (4) · Mental Disorders (4) · Neurodevelopmental Disorders (4) · Behavior (2) · Behavioral Symptoms (2) · Aberrant Motor Behavior in Dementia (1) · Autism Spectrum Disorder (1) · Child Development Disorders, Pervasive (1) · Nervous System Diseases (1) · Social Behavior (1)
Amyloid (1) · brexpiprazole (1)
Dartmouth-Hitchcock Medical Center (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1) · Rhode Island Hospital (1) · University of Minnesota (1)
United States (4)
Anthony Spirito, PhD (1) · James T Craig, Ph.D. (1) · Jennifer C Wolff, PhD (1) · Timothy Piehler (1)